# Junta clínica — PT-pseudo_2ef22b5dd08e (tarea 1)

## Intervención 1 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

Colleagues, this is the record as it arrived, field by field. I read it out and interpret nothing; everything after this is yours.

{
  "case_id": "PT-pseudo_2ef22b5dd08e",
  "pid": "PT-pseudo_2ef22b5dd08e",
  "task": 1,
  "psa": 9.3,
  "age": 66,
  "months": 2,
  "pirads": "4",
  "psad": 0.296,
  "psav": 1.34,
  "psap": 6.2,
  "vol": 31.46,
  "dre": "Normal",
  "bx": "None",
  "cspca": 0.8335312,
  "medhx": "Not reported",
  "meds": "None",
  "notes": "PSA 9.3 ng/mL. PI-RADS 4. PSAD 0.30. Prostate volume 31 mL. csPCa 0.83.",
  "pmhx": [],
  "allergies": [],
  "vitals": {
    "weight": "75 kg",
    "height": "184 cm",
    "bmi": "22.2",
    "bp": "136/76 mmHg",
    "hr": "71 bpm",
    "smoking": "Ex-smoker (24 pack-yr, quit 2020)",
    "last_dental": "6 mo ago",
    "flu_vax": "Oct 2024"
  },
  "enc_dept": "Urology - outpatient",
  "enc_date": "18 Feb 2025",
  "enc_ref": "Dr. C. Peters (GP)",
  "enc_type": "Follow-up - PSA + MRI",
  "note_sections": [
    {
      "s": "Chief complaint",
      "t": "Clinical reassessment indicated due to a persistent upward PSA trajectory coupled with recent multiparametric magnetic resonance imaging results."
    },
    {
      "s": "History",
      "t": "At 66 years of age, this semi-retired harbour pilot seeks review concerning his prostate-specific antigen trajectory, accompanied by a longstanding record of moderate lower urinary tract symptoms (IPSS 8/35). He shares an assisted-living residence with his spouse, who serves as his main point of contact. Physical activity remains a priority, featuring three weekly cycling sessions covering roughly 30 km each, balanced with an alcohol intake of 8 units weekly. His smoking history totals 24 pack-years, though he ceased tobacco use in 2020. Ocular limitations necessitate large-print documents. Recent medical engagements include a gastroenterology visit for standard colonoscopy screening, pulmonary function testing, and a baseline chest radiograph. A laparoscopic gallbladder removal occurred in 2015, entirely separate from his present urological evaluation. He maintains no active comorbidities, takes no prescribed medications, manages occasional seasonal allergies with non-prescription antihistamines, and carries no prior biopsy history. No unexplained weight reduction, skeletal discomfort, or blood in the urine has been reported. General health otherwise appears stable."
    },
    {
      "s": "Physical examination",
      "t": "Per rectum: Normal DRE; digital assessment reveals a uniformly enlarged gland exhibiting consistent firmness without discrete irregularities or lateralised masses. Cardiovascular and respiratory auscultation demonstrate regular rhythms and clear field expansion. Abdominal percussion and palpation confirm a pliable, non-tender cavity lacking palpable hepatosplenomegaly or abnormal growths."
    }
  ],
  "occupation": "harbour pilot (semi-retired)",
  "marital": "Married",
  "living": "Lives in assisted-living facility",
  "next_of_kin": "Spouse / partner (primary contact)",
  "recent_other": [
    "Gastroenterology — surveillance colonoscopy",
    "Radiology — chest X-ray (routine)",
    "Pulmonary function test — known COPD follow-up"
  ],
  "alcohol": "8 units / week",
  "exercise": "Cycling 3x/week, ~30 km",
  "ipss": "IPSS score: 8/35 (moderate LUTS)",
  "admin": "Visual impairment: large-print correspondence requested.",
  "mri_hospital": "Radboudumc",
  "ct": null,
  "active_treatment_flag": 0
}

## Intervención 2 — INTAKE

*the record clerk; reads the file out loud and interprets nothing* · vuelta 1

And this is the same record as the reading form presents it — the panel the urologist sees up front, with the masked documents named but not shown.

You are a senior urologist reviewing a patient case. The structured clinical
record below is shown to you up front, exactly as in the reading form. Some
documents are not shown and must be pulled up via the available tools
(radiology / MRI report, pathology report, previous notes, laboratory
results, PSA history, and the family-history anamnesis) when you need to
consult them.

Case ID: PT-pseudo_2ef22b5dd08e
Task: 1

Encounter: Urology - outpatient on 18 Feb 2025.
Referrer: Dr. C. Peters (GP).
Type: Follow-up - PSA + MRI.

Clinical data (read-only — values loaded from the record):
  - 66-year-old male
  - PSA: 9.3 ng/mL
  - mpMRI — PI-RADS score: 4 (1–2 low · 3 equivocal · 4–5 high risk)
  - PSA density: 0.296 ng/mL²
  - PSA velocity: 1.34 ng/mL/yr
  - Prior PSA: 6.2 ng/mL
  - Prostate volume: 31.46 mL
  - Months since last PSA: 2
  - DRE findings: Normal (Normal · Nodus · Benign · Suspicious · Abnormal · Negative · Not done)
  - Prior biopsy: None (None · Negative · ASAP/HGPIN · Positive)
  - csPCa predicted probability: 0.8335312 (clinically significant PCa = ISUP ≥ 2)

Medical history & medication:
  - Medical history: Not reported
  - Problem list / PMHx: none recorded
  - Current medication: None
  - Allergies: NKA
  - Additional notes: PSA 9.3 ng/mL. PI-RADS 4. PSAD 0.30. Prostate volume 31 mL. csPCa 0.83.

Vitals: weight 75 kg, height 184 cm, BMI 22.2, BP 136/76 mmHg, HR 71 bpm. Smoking: Ex-smoker (24 pack-yr, quit 2020).

Chief complaint: Clinical reassessment indicated due to a persistent upward PSA trajectory coupled with recent multiparametric magnetic resonance imaging results.

History: At 66 years of age, this semi-retired harbour pilot seeks review concerning his prostate-specific antigen trajectory, accompanied by a longstanding record of moderate lower urinary tract symptoms (IPSS 8/35). He shares an assisted-living residence with his spouse, who serves as his main point of contact. Physical activity remains a priority, featuring three weekly cycling sessions covering roughly 30 km each, balanced with an alcohol intake of 8 units weekly. His smoking history totals 24 pack-years, though he ceased tobacco use in 2020. Ocular limitations necessitate large-print documents. Recent medical engagements include a gastroenterology visit for standard colonoscopy screening, pulmonary function testing, and a baseline chest radiograph. A laparoscopic gallbladder removal occurred in 2015, entirely separate from his present urological evaluation. He maintains no active comorbidities, takes no prescribed medications, manages occasional seasonal allergies with non-prescription antihistamines, and carries no prior biopsy history. No unexplained weight reduction, skeletal discomfort, or blood in the urine has been reported. General health otherwise appears stable.

Physical examination: Per rectum: Normal DRE; digital assessment reveals a uniformly enlarged gland exhibiting consistent firmness without discrete irregularities or lateralised masses. Cardiovascular and respiratory auscultation demonstrate regular rhythms and clear field expansion. Abdominal percussion and palpation confirm a pliable, non-tender cavity lacking palpable hepatosplenomegaly or abnormal growths.

Patient info: harbour pilot (semi-retired); Married; Lives in assisted-living facility.
Next of kin: Spouse / partner (primary contact).

Lifestyle: alcohol 8 units / week; exercise Cycling 3x/week, ~30 km; IPSS score: 8/35 (moderate LUTS).

Recent other appointments: Gastroenterology — surveillance colonoscopy; Radiology — chest X-ray (routine); Pulmonary function test — known COPD follow-up.
Admin: Visual impairment: large-print correspondence requested.

Information you can request via tools (the masked "Extended EHR view" — what
the urologist would actively pull up during the consult):
  - radiology / MRI report (full mpMRI prose behind the headline imaging values)
  - pathology report (any prior biopsy on record)
  - previous GP / urology consultation notes
  - laboratory results (full panel)
  - PSA history (trend / velocity beyond the headline value)
  - family history of prostate cancer (anamnesis)

Question:
Based on this patient's data, do you recommend biopsy?


One correction to that last paragraph before anybody acts on it: the documents this task actually serves are radiology_report, psa_trend, previous_notes, laboratory_results, plus the family-history anamnesis. There is NO pathology report to pull up in a task-1 biopsy decision — the prior-biopsy status on the panel above is all the pathology on record, and whatever the previous notes say about it. Nobody should ask for one, and nobody should quote one.

## Intervención 3 — EXPERT-STRUCTURED

*Expert 1, Extra-Trees on the structured panel only; opening bid with an error bar* · vuelta 1

Expert 1 here — the classifier that reads the structured panel and nothing else. My bid:

SUGGESTION: BIOPSY   p(biopsy) = 0.90
  uncertainty  +/- 0.05 epistemic (95% band 0.80-0.99); among patients I cannot tell apart the outcome was 0.48 of 1.00 mixed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; the levels are what moved my prediction across the series, not what a urologist would mark)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  comorbidity = none recorded (21% of my signal; from pmhx_hypercholesterolaemia, n_comorbidities)
  noted      age = 66 (2% of my signal; from age) · DRE = Normal (10% of my signal; from dre_suspicious) · PSA = 9.3 ng/mL (3% of my signal; from log_psa, psav) · prostate volume = 31.46 mL (1% of my signal; from log_vol, vol) · PSA density = 0.296 (0% of my signal; from psad_calc, log_psad) · csPCa probability = 0.83 (1% of my signal; from cspca) · PI-RADS = 4 (20% of my signal; from pirads_ge4, pirads_ge3)
  not used   family history
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 88% of the time over the 33 labelled cases in this tier

I read 39 raw variables, all from the panel — nothing from the mpMRI prose, the PSA
trajectory, the previous notes or the laboratory. Out-of-fold over 91 labelled cases: AUC
0.758, balanced accuracy 0.625.
The final call is the chair's.

## Intervención 4 — EXPERT-COHORT

*cohort criterion; what the labelled series did in this exact situation* · vuelta 1

This patient's situation: never biopsied. My criterion answers BIOPSY.

The criterion: sample when the mpMRI shows a PI-RADS 3 or higher lesion; defer at PI-RADS 1-2. In the labelled series this criterion matched the reading urologist in 24 of 24 cases in exactly this situation.

Like Expert 1, I have read ONLY the visible panel — not the mpMRI prose, the PSA trajectory, the
previous notes or the laboratory panel. Departing from me needs a specific finding from a document
somebody actually opened, named out loud; not a restatement of the panel numbers I already used.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel only; 'decisive' marks the variable the rule turns on)
  decisive   PI-RADS = 4
  important  prior biopsy = None
  noted      age = 66 · DRE = Normal · PSA = 9.3 ng/mL · prostate volume = 31.46 mL · PSA density = 0.296 · comorbidity = none recorded
  not used   family history, csPCa probability
CONFIDENCE: clear — the rule matched the reading urologist in 24 of 24 labelled cases

## Intervención 5 — EXPERT-EXPERIENCE

*case library; the closest labelled precedents and what the reading urologist did with them* · vuelta 1

I recall 23 men I have seen in this same situation (None prior biopsy). The 3 most similar patients, and what the reading urologist did:
  1. distance 1.49: PI-RADS 4, PSA 13.9, PSAD 0.177, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P4 in 65 year old patient"
  2. distance 1.83: PI-RADS NA, PSA 4.5, PSAD 0.095, age 67, DRE Normal -> DEFER (clear). He wrote: "Normal MRI. No biopsy"
  3. distance 1.87: PI-RADS 5, PSA 9.0, PSAD 0.409, age 65, DRE Normal -> BIOPSY (clear). He wrote: "P5 in a man with high PSA"

PRECEDENT: BIOPSY (weighted vote 0.69 for biopsy). Distance-weighted precedent is strong here (0.92 leave-one-out).

What my professional experience contributes: it shows what this urologist looks at and how he phrases the call. These memories do not establish facts about this patient. Nobody may cite a precedent's grade, PSA or MRI as if it were his.

WHAT THE READING UROLOGIST WEIGHED IN THESE PRECEDENTS — in the form's vocabulary, with this man's values (weighted majority of the 3 nearest labelled traces; the distance itself is on PI-RADS, prior biopsy first)
  decisive   PI-RADS = 4
  important  prior biopsy = None · PSA = 9.3 ng/mL
  noted      family history = not opened (0 of 91) · age = 66 · DRE = Normal · prostate volume = 31.46 mL · PSA density = 0.296 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: borderline — the library is right 92% of the time in this situation out of fold

## Intervención 6 — EXPERT-TRACE

*Expert 4, trace model; which documents the reading urologist opens and what he weighs in this situation* · vuelta 1

Expert 4 here — the model of how the reading urologist works a case like this. Predicted from his 23 labelled traces in this situation (None prior biopsy): a per-field model where it beats the mode out of fold (prior-biopsy weight, DRE weight, PI-RADS weight, and whether he opens the laboratory), the mode elsewhere.

WHAT HE OPENS: radiology_report, psa_trend, previous_notes.

WHAT HE WEIGHS — in the form's vocabulary, with this man's values (these are the levels that go on the form, unless a colleague shows a reason to move one)
  decisive   PI-RADS = 4
  important  age = 66 · PSA = 9.3 ng/mL
  noted      prior biopsy = None · family history = not opened (0 of 91) · DRE = Normal · prostate volume = 31.46 mL · PSA density = 0.296 · comorbidity = none recorded
  not used   csPCa probability
CONFIDENCE: clear — the level the reading urologist records in this situation, from his labelled traces

MODERATOR: that list of documents is the plan — exactly those, no more. Every document opened beyond what
he would open is scored against the conference as an unnecessary reveal; every document left closed
leaves a variable he weighed without its source. Attach the question each one must answer.

## Intervención 7 — EXPERT-EAU

*EAU guideline specialist; speaks only from the guideline text he retrieved* · vuelta 1

GUIDELINE
The retrieved guidelines suggest that when MRI shows a suspicious lesion (PI-RADS $\ge 4$), targeted biopsy with perilesional sampling can be obtained. The guideline states: "Where MRI has shown a suspicious lesion, MR-targeted biopsy can be obtained through cognitive guidance, ultrasound/MR fusion software or direct in-bore guidance."

WHAT THE EXPERTS' BIDS DO NOT SETTLE
EXPERT-STRUCTURED, I note that the guideline makes the variable 'prior biopsy = None' context, whereas the guideline suggests that when MRI is positive (PI-RADS $\ge 4$), a biopsy should be obtained. The guideline requires the MRI finding, which is present here, to be the primary driver, rather than the prior biopsy status. The guideline suggests that the PI-RADS score of 4 is the key factor, which is marked 'decisive' by EXPERT-COHORT. The guideline requires the PI-RADS score to be $\ge 4$ to trigger the consideration of biopsy. The guideline needs the comparison MRI or a due confirmatory biopsy to establish the next step, as the current situation is defined by the PI-RADS 4 finding.

WHAT THE DOCUMENTS MUST SETTLE
previous_notes - the prior biopsy status: None means the patient is eligible for a biopsy based on the PI-RADS 4 finding, which aligns with the guideline's recommendation for obtaining a biopsy when MRI is positive.
radiology_report - whether the lesion is compared against an earlier study: Unchanged does not support re-sampling, new or larger does
psa_trend - the PSA velocity: 1.34 ng/mL/yr indicates a rising trend, which is a factor in the overall clinical context, though the guideline focuses on the imaging finding.
laboratory_results - the PSA density: 0.296 ng/mL/cc falls into the higher risk category, which, when combined with PI-RADS 4, supports the need for further investigation according to risk-adapted matrices.

## Intervención 8 — MODERATOR

*chairs the discussion; sets the open questions and assigns the documents* · vuelta 1

The case strongly points towards a biopsy given the PI-RADS 4 finding and the guideline recommendation, but we need to establish the context from the radiology report and previous notes.

The documents for this session were fixed by EXPERT-TRACE; what I add is the question each one has to answer, and the open questions for the room.

REGISTRAR — pull these up, and answer exactly the question attached to each:
  radiology_report (get_mri_report) -> Must state whether the lesion is compared against an earlier study.
  psa_trend (get_psa_trend) -> Must clarify the clinical significance of the PSA velocity of 1.34 ng/mL/yr.
  previous_notes (get_previous_notes) -> Must detail the prior biopsy status, surveillance protocol, and planned management.

OPEN QUESTIONS for this conference — these are what the decision hangs on:
  Q1. What does the radiology_report state regarding whether the lesion is compared against an earlier study?
  Q2. What does the previous_notes state regarding the prior biopsy status, surveillance protocol, and planned management?

## Intervención 9 — REGISTRAR

*the registrar who pulls up documents; reports what they say, nothing else* · vuelta 1

WHAT I FOUND
radiology_report
The lesion is compared against an earlier study: new.
LESION: PI-RADS 4 lesion in the left peripheral zone (base-to-mid), 14 mm.

psa_trend
The clinical significance of the PSA velocity of 1.34 ng/mL/yr is a rising trend.

previous_notes
PRIOR GRADE: not recorded
BIOPSY SESSIONS: None recorded
SURVEILLANCE: not recorded
TREATMENT: none recorded

WHAT I DID NOT OPEN
family-history anamnesis, because it was not listed in the plan and its absence does not change the immediate decision based on imaging and trend.

WHAT THIS SUPPORTS
FOR sampling this patient now
PI-RADS 4 finding supports biopsy per EXPERT-COHORT and EXPERT-EAU guidelines.
PSA velocity of 1.34 ng/mL/yr indicates a rising trend, supporting further investigation.
laboratory_results PSA density of 0.296 ng/mL/cc falls into the higher risk category, supporting further investigation.

AGAINST sampling this patient now
nothing

WHERE THIS LEANS
LEAN: biopsy

## Intervención 10 — EXPERT-PSA

*Expert 2, PSA projector; the trajectory behind the headline PSA, with a conformal band* · vuelta 1

Expert 2 here — the PSA projector. I read only the serial PSA the registrar opened.

TRAJECTORY: RISING (borderline). Last value 9.30 ng/mL over 4 points spanning 31 months; velocity +0.94 ng/mL per year; doubling time about 67 months.
PROJECTION at 6 months: 14.6 ng/mL, conformal 95% band 4.2-50.8.

Read the band before the point: it is wide by construction, and I only call a direction when the whole
band clears the last value. This does not vote on the biopsy — a rising PSA in a man with a known
diagnosis is the disease behaving as known — it tells the chair how fast the number is moving.

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (the serial PSA only)
  noted      PSA = 9.3 ng/mL
  not used   prior biopsy, family history, age, DRE, prostate volume, PSA density, csPCa probability, PI-RADS, comorbidity
CONFIDENCE: borderline — the conformal band does not clear the last value

## Intervención 11 — EXPERT-FUSION

*Expert 3, Extra-Trees on panel + laboratory + MRI prose; speaks only on documents that were opened* · vuelta 1

Expert 3 here — the fusion classifier. I read the panel, the mpMRI report — the laboratory panel was not opened, so that block is imputed and my band is wider for it; nothing from the previous notes or the PSA series.

SUGGESTION: BIOPSY   p(biopsy) = 0.85
  uncertainty  +/- 0.06 epistemic (95% band 0.74-0.96), of which 0.01 comes from values that had to be imputed
  reliability  HIGH ('firm' tier) — out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

VARIABLES I WEIGHED — in the form's vocabulary, with this man's values (panel + the documents that were opened; PI-RADS here means the report's own wording — DWI restriction, lesion size — not the score)
  decisive   prior biopsy = None (43% of my signal; from bx_positive, bx_none)
  important  PI-RADS = 4 (22% of my signal; from rad_dwi_restriction, rad_lesion_ge15mm)
  noted      PSA = 9.3 ng/mL (21% of my signal; from fpsa_lt15, psa_delta_prev) · prostate volume = 31.46 mL (4% of my signal; from log_vol, vol) · PSA density = 0.296 (0% of my signal; from psad_calc) · comorbidity = none recorded (4% of my signal; from n_comorbidities, on_alpha_blocker)
  not used   family history, age, DRE, csPCa probability
CONFIDENCE: clear — 'firm' tier; out-of-fold it was right 89% of the time over the 37 labelled cases in this tier

Out-of-fold AUC 0.794. I am the only expert that has read the report's
wording, and I still cannot see the prior grade or the surveillance history: those are in the notes, and
the registrar has to carry them.

## Intervención 12 — PANEL-PROTOCOL

*the panel's written protocol; consolidates the experts by rule and says which rule fired* · vuelta 1

The panel protocol, applied to what is on the board:

  EXPERT-STRUCTURED  BIOPSY, p(biopsy)=0.90  ('firm' tier; weight 3.0)
  EXPERT-FUSION      BIOPSY, p(biopsy)=0.85  ('firm' tier, fusion_nolab; weight 4.5)
  EXPERT-EXPERIENCE  BIOPSY, p(biopsy)=0.69  (k=3 precedents; does not vote)
  EXPERT-COHORT      BIOPSY  (rule pirads_ge_3; does not vote)

  documented prior grade in the opened documents: none recorded

RULE THAT FIRED: cohort criterion (pirads_ge_3) — carried by EXPERT-COHORT.
PANEL ANSWER: BIOPSY. It matched the reading urologist in 24 of 24 labelled cases in exactly this situation (never biopsied).

THE BOARD'S VARIABLES — value · what each expert marked · what goes on the form
  bx           None                         E1:DEC E3:DEC cohort:IMP library:IMP E2:—            -> noted
  fh           not opened (0 of 91)         E1:— E3:— cohort:— library:not E2:—                  -> not_used (raised from noted by the board)
  age          66                           E1:not E3:— cohort:not library:not E2:—              -> important
  dre          Normal                       E1:not E3:— cohort:not library:not E2:—              -> not_used (raised from noted by the board)
  psa          9.3 ng/mL                    E1:not E3:not cohort:not library:IMP E2:not          -> important
  vol          31.46 mL                     E1:not E3:not cohort:not library:not E2:—            -> noted
  psad         0.296                        E1:not E3:not cohort:not library:not E2:—            -> noted
  cspca        0.83                         E1:not E3:— cohort:— library:— E2:—                  -> not_used
  pirads       4                            E1:not E3:IMP cohort:DEC library:DEC E2:—            -> decisive
  comorbidity  none recorded                E1:IMP E3:not cohort:not library:not E2:—            -> noted
  (DEC decisive · IMP important · not noted · — not used; the last column is the level recorded, from the trace of the reading urologist)

Confidence to record: clear.

CHAIR: this is the panel's position. You sign it, and you write why in the room's words — naming what the registrar retrieved. If you believe a retrieved finding overturns it, name that finding with its value; the burden is on the finding, not on the panel.

## Intervención 13 — VERIFIER

*second EAU reader; checks against the guideline whether this can be decided yet* · vuelta 1

SUFFICIENCY
The documents the registrar opened (radiology_report, psa_trend, previous_notes) have addressed the moderator's questions. The radiology report states the lesion is "new" compared to an earlier study, and the previous notes state "None recorded" for prior biopsy status, along with no surveillance or treatment recorded.

ALIGNMENT WITH THE PANEL
The retrieved evidence aligns with the PANEL-PROTOCOL's answer of BIOPSY. Specifically, the registrar's finding that the lesion is "new" supports the need for intervention, and the prior biopsy status being "None recorded" aligns with the cohort criterion firing.

THE OPEN QUESTIONS, ONE BY ONE
Q1. What does the radiology_report state regarding whether the lesion is compared against an earlier study? The radiology_report states: "The lesion is compared against an earlier study: new."
Q2. What does the previous_notes state regarding the prior biopsy status, surveillance protocol, and planned management? The previous_notes state: "PRIOR GRADE: not recorded," "BIOPSY SESSIONS: None recorded," and "SURVEILLANCE: not recorded," "TREATMENT: none recorded."

WHAT CARRIES WEIGHT, AND WHY
decisive: pirads: 4 (decisive) because EXPERT-COHORT marks it decisive, and the guideline requires PI-RADS $\ge 4$ to trigger consideration of biopsy.
important: prior biopsy = None (important) because EXPERT-STRUCTURED and EXPERT-FUSION mark this as decisive, and the guideline suggests biopsy when MRI is positive and prior biopsy is absent.
noted: psa: 9.3 ng/mL (important) because EXPERT-STRUCTURED and EXPERT-FUSION mark this as important, reflecting the high PSA level in the context of the finding.
my confidence in the record as it stands is clear, as the trace model's plan was fully executed and the retrieved data supports the panel's conclusion.

MY SUGGESTION TO THE CHAIR
I suggest proceeding with a targeted biopsy based on the PI-RADS 4 finding and the absence of a prior biopsy, as supported by the EAU guideline and the consensus of the experts.

VERDICT: ready | SUGGEST: biopsy | MISSING: none

[The conference closes after pass 1: the verifier called the record ready. The chair decides on the record as it stands.]

## Intervención 14 — CHAIR

*the senior urologist who signs the decision* · vuelta 1

MY DECISION: BIOPSY   (confidence: clear)

66 y/o male, biopsy-naive, with PI-RADS 4 lesion and PSA density 0.296. The PI-RADS 4 finding warrants targeted biopsy, as no prior pathology exists to contraindicate sampling. The rising PSA velocity of 1.34 ng/mL/yr supports proceeding with biopsy.

What carried weight: bx=noted, age=important, psa=important, vol=noted, psad=noted, pirads=decisive, comorbidity=noted
Sections retrieved: radiology_report, psa_trend, previous_notes
